Treatment Alternatives in iSGS (NoAAC PR-02 Study)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alexander Gelbard, MD
Vanderbilt University Medical Center
Principal Investigator - David O. Francis, MD, MS
Vanderbilt University Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Sydney
St Leonards, Australia
- Landspitali University Hospital
Reykjavik, Iceland
- Charing Cross Hospital, Imperial College London
London, United Kingdom
- the University of Alabama at Birmingham
Birmingham, Alabama, United States
- Mayo Clinic
Scottsdale, Arizona, United States
- University of California Irvine
Irvine, California, United States
- Loma Linda University Health Care
Loma Linda, California, United States
- University of California Los Angeles
Los Angeles, California, United States
- University of Southern California
Los Angeles, California, United States
- Stanford University
Palo Alto, California, United States
- University of California San Diego
San Diego, California, United States
- University of California San Francisco
San Francisco, California, United States
- University of Colorado
Denver, Colorado, United States
- University of Miami
Miami, Florida, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- Augusta University
Augusta, Georgia, United States
- Bastian Voice Institute
Downers Grove, Illinois, United States
- University of Iowa
Iowa City, Iowa, United States
- Louisiana State University
Baton Rouge, Louisiana, United States
- Johns Hopkins
Baltimore, Maryland, United States
- Harvard Medical School -Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- University of Nebraska
Omaha, Nebraska, United States
- New York University Medical Center
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Duke University
Durham, North Carolina, United States
- University of Cincinatti
Cincinnati, Ohio, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- the Ohio State University Wexner Medical Center
Columbus, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- Temple University
Philadelphia, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Texas Southwestern
Dallas, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- University of Virginia
Charlottesville, Virginia, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Aug 2015
- Primary completion
- 10 Sept 2020
- Completion
- 10 Sept 2020
- Last update posted
- 28 Oct 2021
- Registered enrollment
- 1,239
- Registry id
- NCT02481817
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.